136 related articles for article (PubMed ID: 8473041)
1. Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: differences in in vitro and in vivo systems.
Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
Int J Cancer; 1993 Apr; 53(6):1013-6. PubMed ID: 8473041
[TBL] [Abstract][Full Text] [Related]
2. DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
Saeki S; Nishiyama M; Toge T
Hiroshima J Med Sci; 1995 Sep; 44(3):55-63. PubMed ID: 8567314
[TBL] [Abstract][Full Text] [Related]
3. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].
Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1037-41. PubMed ID: 7685584
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
5. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
[TBL] [Abstract][Full Text] [Related]
6. Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
Gan Y; Mo Y; Kalns JE; Lu J; Danenberg K; Danenberg P; Wientjes MG; Au JL
Clin Cancer Res; 2001 May; 7(5):1313-9. PubMed ID: 11350900
[TBL] [Abstract][Full Text] [Related]
7. [DT-diaphorase].
Mikami K; Shirakusa T; Tsuruo T
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1606-10. PubMed ID: 9309161
[TBL] [Abstract][Full Text] [Related]
8. Molecular targeting of mitomycin C chemotherapy.
Nishiyama M; Suzuki K; Kumazaki T; Yamamoto W; Toge T; Okamura T; Kurisu K
Int J Cancer; 1997 Aug; 72(4):649-56. PubMed ID: 9259406
[TBL] [Abstract][Full Text] [Related]
9. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.
Mikami K; Naito M; Tomida A; Yamada M; Sirakusa T; Tsuruo T
Cancer Res; 1996 Jun; 56(12):2823-6. PubMed ID: 8665520
[TBL] [Abstract][Full Text] [Related]
10. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.
Malkinson AM; Siegel D; Forrest GL; Gazdar AF; Oie HK; Chan DC; Bunn PA; Mabry M; Dykes DJ; Harrison SD
Cancer Res; 1992 Sep; 52(17):4752-7. PubMed ID: 1324793
[TBL] [Abstract][Full Text] [Related]
11. Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts.
Cowen RL; Patterson AV; Telfer BA; Airley RE; Hobbs S; Phillips RM; Jaffar M; Stratford IJ; Williams KJ
Mol Cancer Ther; 2003 Sep; 2(9):901-9. PubMed ID: 14555709
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
Sakamoto N; Toge T; Nishiyama M
Hiroshima J Med Sci; 1997 Jun; 46(2):67-73. PubMed ID: 9232934
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.
Wang X; Doherty GP; Leith MK; Curphey TJ; Begleiter A
Br J Cancer; 1999 Jun; 80(8):1223-30. PubMed ID: 10376975
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
[TBL] [Abstract][Full Text] [Related]
15. DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.
Ross D; Siegel D; Beall H; Prakash AS; Mulcahy RT; Gibson NW
Cancer Metastasis Rev; 1993 Jun; 12(2):83-101. PubMed ID: 8375023
[TBL] [Abstract][Full Text] [Related]
16. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
Lambert PA; Kang Y; Greaves B; Perry RR
J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
[TBL] [Abstract][Full Text] [Related]
17. Immunological quantitation of DT-diaphorase in carcinoma cell lines and clinical colon cancers: advanced tumors express greater levels of DT-diaphorase.
Mikami K; Naito M; Ishiguro T; Yano H; Tomida A; Yamada T; Tanaka N; Shirakusa T; Tsuruo T
Jpn J Cancer Res; 1998 Sep; 89(9):910-5. PubMed ID: 9818026
[TBL] [Abstract][Full Text] [Related]
18. Expression of the prodrug-activating enzyme DT-diaphorase via Ad5 delivery to human colon carcinoma cells in vitro.
Misra V; Klamut HJ; Rauth AM
Cancer Gene Ther; 2002 Feb; 9(2):209-17. PubMed ID: 11857040
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation.
Sagara N; Katoh M
Cancer Res; 2000 Nov; 60(21):5959-62. PubMed ID: 11085512
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
Lee JH; Naito M; Nakajima M; Tsuruo T
Cancer Chemother Pharmacol; 1993; 33(3):215-20. PubMed ID: 7505723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
